First time users: You will need to check your degree as you created an ACMG account. The system designates educational credits according to your degree. Be sure you are logged in (do you see your name on the top right under the ACMG Genetics Academy logo?). If not, log in before proceeding.
For technical support, please send an email to: education@acmg.net or call 301-718-9603.
Or click on the "Help" icon on the left-hand side of your screen for more information.Support Center Hours: Monday- Friday 9:00 am - 5:00 pm Eastern Time
Date of Release: July 19, 2021
Expiration Date: July 1, 2023
Credits offered: CME, P.A.C.E.®, NSGC
Estimate time of completion: 62 hours
Course must be completed by the expiration date and NSGC credits are reported one time.
www.acmgeducation.net
Course Description
The 2021 ACMG Annual Clinical Genetics Meeting Digital Edition presents both research and clinical topics that promote the science and the practice of clinical genetics and genomics. Sessions focus on the latest discoveries of the etiology and the pathogenesis of genetic disorders, the latest developments in genetic testing and screening, the laboratory’s role in the diagnosis of genetic disorders, the treatment of genetic disorders in children and adults, the delivery of genetic services, and more.
This course contains accredited sessions with recorded content and live Q&A, ondemand sessions, scientific sessions, and platform sessions.
Target Audience
All healthcare professionals interested in the diagnosis, management, treatment and prevention of genetic conditions and increasing their understanding of the genetic basis of common, chronic health problems affecting both children and adults will find the programming applicable to their practice. These select sessions from the ACMG Annual Meeting are targeted for the following professionals:
Learning Objectives
At the conclusion of this session, participants should be able to:
Continuing Education Information
CME, P.A.C.E®., NSGC Educational Credits
Continuing Medical Education (CME)AccreditationThe American College of Medical Genetics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Credit DesignationThe American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 62 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country.Non-physicians may request a certificate of attendance for their participation.
Genetic Counselor Credit
NSGC CEUs - The National Society of Genetic Counselors (NSGC) has authorized ACMG to offer up to 6.02 CEUs or 62.0 Category 1 contact hours for the activity 2021 ACMG Annual Clinical Genetics Meeting – Digital Edition. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
ACMG will report completed accredited sessions to NSGC for credit certificates on December 3, 2021, and December 8, 2022, and July 3, 2023. Submissions outside of these parameters may incur a processing fee of $40. All course work must be reported one time as a total and not cumulated. Please watch for email from ACMG for verification of reporting.
P.A.C.E.® CEU's ACMG is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program.ACMG is approved by the Florida Board of Clinical Laboratory Personnel as CE Provider (50-11878). This course is registered with CEBroker # 20-865016. ACMG is approved by the California Department of Health Services through the ASCLS P.A.C.E.®. This activity has been approved for 62 P.A.C.E.® CEU's.
Participation Instructions (OnDemand)
Disclosure Statement
It is the policy of the American College of Medical Genetics and Genomics to plan and implement all of its educational activities in accordance with the ACCME Essentials and Areas and ACCME® Policies to ensure balance, independence, objectivity and scientific rigor. In accordance with the ACCME® Standards for Commercial Support, everyone (speakers, moderators, committee members and staff) who is in a position to control the content of an educational activity certified for AMA PRA Category 1 Credit™ is required to disclose all financial relationships with any commercial interests within the past 12 months that creates a real or apparent conflict of interest. Individuals who do not disclose will be disqualified from participating in a CME activity.
This disclosure pertains to relationships with ACCME-defined commercial interests whose products or services may be related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be managed prior to the educational activity. ACMG will identify, review and resolve all conflicts of interests prior to an educational activity being delivered to learners.
NOTE:
Content Validation and Fair Balance
Off-Label Uses of Products
When an off-label use of a product, or an investigational use not yet approved for any purpose, is discussed during an educational activity, the accredited sponsor shall require the speaker to disclose that the product is not labeled for the use under discussion, or that the product is still investigational. Discussions of such uses shall focus on those uses that have been subject of objective investigation.
HIPAA Compliance by Faculty
The ACMG supports medical information privacy. While the ACMG is not a “covered entity” under HIPAA 1996 and therefore is not required to meet these standards, ACMG wishes to take reasonable steps to ensure that the presentation of individually identifiable health information at ACMG-sponsored events has been properly authorized. All presenters have completed a form indicating whether they intend to present any form of individually identifiable healthcare information. If so, they were asked either to at that a HIPAA-compliant consent form is on file at their institution, or to send ACMG a copy of the HIPAA compliance form. This information is on record at the ACMG Administrative Office and will be made available upon request.
Disclaimer
ACMG educational programs are designed primarily as an educational tool for health care providers who wish to increase their understanding of the application of genomic technologies to patient care. The ACMG does not endorse or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and s or exclusive of other procedures and s that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or, a healthcare provider should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen.
Questions regarding CE credit should be directed to education@acmg.net
Financial Disclosures
The following reported disclosures and none are relevant to the content of this course. All of the relevant financial relationships listed for these individuals have been mitigated.
Speakers and Moderators Disclosures
Presenters and moderators have disclosed the following:[Last name, First Name, Degree(s)]
Name
Role(s)
Disclosure
Abul-Husn, Noura,MD, PhD, MS, FACMG
Presenter
Previously employed relationship with Regeneron Pharmaceuticals; Speaker/Speaker's Bureau relationship with Genentech
Adashi, Eli,MD, MS
Consultant relationship with Ohana Biosciences
Ammous, Zeinab, MD
Consultant relationship with Travere Therapeutics; Consultant relationship with CoA Therapeutics
Berry, Susan, MD
DSMB Member relationship with Sanofi; Clinical Trial Site PI relationship with Hemoshear; Clinical Trial Site PI relationship with Arturus
Biffi, Alessandra, MD
reserach funding relationship with Altheia Science
reserach funding, patent and royalties relationship with Orchard Therapeutics
Brigatti, Karlla, MS
Advisory Committee Member relationship with Novartis Gene Therapies
Burghes, Arthur, PhD
Consultant relationship with Norvartis Gene Therapy
Cherqui, Stephanie, PhD
Owner/Founder relationship with Stelios Therapeutics Inc; Consultant relationship with AVROBIO
Chung, Wendy,MD, PhD
Scientific Medical Advisor relationship with Regeneron Genetic Center
Speaker/Speaker's Bureau relationship with Rhythm
Cunniff, Christopher, MD
Consultant relationship with Sterigenics; Advisory Committee Member relationship with Biogen; Advisory Committee Member relationship with Amgen
Daly, Mark, PhD
Owner/Founder relationship with MAZE Therapeutics
Dhar, Shweta, MD
Owner/Founder relationship with PanGenomics India
Dimmock, David, MD
Advisory Committee Member relationship with Audentes
Advisory Committee Member relationship with Biomarin
Advisory Committee Member relationship with Complete Genomics
Flannery, David, MD
Stockholder relationship with Salus Telehealth
Francomano, Clair, MD
Consultant relationship with Acer Therapeutics
Scientific Medical Advisor relationship with Kyani International
Gillingham, Melanie, PhD
Patents/Royalties relationship with Ultragenyx; Consultant relationship with Reneo; Speaker/Speaker's Bureau relationship with Vitaflo; Speaker/Speaker's Bureau relationship with Rockpointe CME; Speaker/Speaker's Bureau relationship with Total CME
Gregg, Anthony, MD, MBA, FACOG, FACMG
Consultant relationship with I do participate in medical legal consulting - defense
Hajirasouliha, Iman, PhD
Owner/Founder relationship with STORK AI
Hakim, Alan, MB MA
Consultant relationship with The Ehlers-Danlos Society
Harding, Cary, MD
Scientific Medical Advisor relationship with BioMarin Pharmaceutical Corp.; Research Funding relationship with Ultragenyx Pharmaceutical; Scientific Medical Advisor relationship with Sanofi/Genzyme; Scientific Medical Advisor relationship with Synlogic, Inc.
Haywood, Trent, MD
Founder, Knowality LLC
Hirschhorn, Joel, MD/PhD
Advisory Committee Member relationship with Camp4 Therapeutics
Kamihara, Junne, MD, PhD
Research Funding relationship with ACD-Biotechne
Consultant relationship with EMD Millipore Sigma
Consultant relationship with Foundation Medicine, Inc.
Speaker/Speaker's Bureau relationship with NanoString Technologies
Owner/Founder relationship with PanTher Therapeutics
Consultant relationship with Pfizer
Research Funding relationship with PureTech
Research Funding relationship with Ribon Therapeutics
Owner/Founder relationship with Rome therapeutics
Consultant relationship with Rome Therapeutics
Owner/Founder relationship with TellBio, Inc.
Consultant relationship with Third Rock Ventures
Karaa, Amel, MD
Research Funding relationship with Idorsia
Research Funding relationship with Impeto
Research Funding relationship with Protalix
Research Funding relationship with Sanofi Genzyme
Consultant relationship with Stealth biotherapeutics
Research Funding relationship with Takeda
Kuhn, Robert, PhD
Patents/Royalties relationship with UCSC Genome Browser authors
Lianoglou, Billie, LCGC
Employee relationship with Denali Therapeutics
Lin, Angela, MD, FACMG
Consultant relationship with Massachusetts Department Public Health
Luedecke, Amanda, MS
Consultant relationship with MyGeneCounsel
Martin, Kimberly, MD
Consultant relationship with Natera
McBride, Kim, MD
Research Funding relationship with Biomarin; Research Funding relationship with Abeona; Research Funding relationship with Homology
Murray, Michael, MD
Scientific Medical Advisor relationship with 54gene
Parikh, Sumit, MD
Employee relationship with Cleveland Clinic; Scientific Medical Advisor relationship with CHAMP Foundation; Research Funding relationship with Astellas; Scientific Medical Advisor relationship with UMDF; Research Funding relationship with Acadia; Research Funding relationship with Minovia
Pratt, Victoria, PhD
Advisory Committee Member relationship with Avalon Healthcare, LLC
Robinson, Peter, MD, PhD
Patents/Royalties relationship with The Jackson Laboratory
Scott, Stuart, PhD
Consultant relationship with Sema4
Simpson, Joe Leigh, MD
Advisory Committee Member relationship with Illumina
Steiner, Robert, MD
Employee relationship with PreventionGenetics; stock and consultant relationship with Acer Therapeutics
Stewart, Douglas, MD
Consultant relationship with Genome Medical, Inc
Sutton, V. Reid, MD
Laboratory Director, Salary Support relationship with Baylor Genetics
Van den Veyver, Ignatia, MD, FACMG
Reagents to support NIH-funded project relationship with Illumina, SAB member, no financial compensation relationship with Baylor Genetics
Venditti, Charles, MD/PhD
Research Funding relationship with Moderna; Research Funding relationship with LogicBio; Research Funding relationship with AskBio; Research Funding relationship with Translate Bio
Vora, Neeta, MD, FACMG
Research Funding relationship with Illumina
Wasserstein, Melissa, MD
Consultant relationship with Sanofi Genzyme; Consultant relationship with Sanofi Genzyme; Research Funding relationship with Sanofi-Genzyme; Consultant relationship with Takeda; Research Funding relationship with Ara Parseghian Medical Research Fund; Research Funding relationship with BioMarin; Research Funding relationship with Cure Sanfilippo Foundation; Research Funding relationship with Dana's Angels Research Trust; Research Funding relationship with Firefly Fund; Research Funding relationship with Orchard Therapeutics; Research Funding relationship with PassageBio; Research Funding relationship with Travere Therapeutics; Research Funding relationship with Ultragenyx
Weitzel, Jeffrey, MD
Speaker/Speaker's Bureau relationship with AstraZeneca
Williamson Dean, Lori, MS
Advisory Committee Member relationship with GeneDx
Yu, Timothy, MD, PhD
Scientific Medical Advisor relationship with GeneTx Therapeutics; Scientific Medical Advisor relationship with Eisai G2D2; Scientific Medical Advisor relationship with Alnylam
The following moderators and presenters have nothing to disclose:
Abu-El-Haija, Aya, MD MPH
Akbar, Fizza, MS
Akkari, Yassmine, PhD
Alkuraya, Fowzan, MD, FACMG
Appelbaum, Paul, MD
Bailey, Diana, MS
Berg, Jonathan, MD/PhD
Berry, Gerard, MD
Bielas, Stephanie, PhD
Bien-Willner, Gabriel, PhD, MD
Bird, Lynne, MD
Bowling, Kevin, PhD
Bradley, David, MD
Buchanan, Adam, MS
Carey, David, PhD
Casanova, Jean-Laurent, MD, PhD
Chanprasert, Sirisak, MD
Chung, Brian Hon-Yin, MS, MD
Clayton, Ellen, MD, JD
Cusmano-Ozog, Kristina, MD
Cutting, Garry, MD
Davis, Erica, PhD
Dobin, Sheila, PhD
Dow, Margaret, MD
Ebbert, Mark, PhD
Edmondson, Andrew, MD/PhD
Elias, Ellen, MD
Elsea, Sarah, PhD, FACMG
Emrick, Lisa, MD
Eno, Celeste, PhD
Erwin, Angelika, MD, PhD
Evans, Rebecca, CGC
Fahrner, Jill, MD/PhD
Farooqi, Sadaf, PhD, FRCP, FMedSci
Fullerton, Stephanie, PhD
Gavrilova, Ralitza, MD
Geddes, Gabrielle, MD
Giordano, Jessica, MS
Glinton, Kevin, MD/PhD
Gray, Kathryn, MD/PhD
Goldstein, Alisa, PhD
Grochowsky, Angela, MD
Goldstein, Amy, MD
Gropman, Andrea, MD
Gupta, Punita, MD
Haldeman-Englert, Chad, MD
Hisama, Fuki, MD
Hodge, Jennelle, PhD
Hoenig, Megan MS
Hurst, Anna, MD, MS, FACMG
Jensik, Philip, PhD
Ji, Yuan, MS, PhD
Jobanputra, Vaidehi, PhD
Jones, Marilyn, MD
Kahn, Jeffrey, PhD, MPH
Kashmola-Perez, Iman, MS, LGC
Keppler-Noreuil, Kim, MD, FACMG
Khalek, Nahla, MD, MPH
King, Jennifer, MD
Kirmani, Salman, MBBS, FACMG
Klein, Christopher, MD
Koenig, Barbara, PhD
Krawitz, Peter, MD, PhD
Kraybill, Donald, PhD
Langlois, Sylvie, MD
Laukaitis, Christina, MD, PhD
Leung, Marco, PhD, FACMG
Marshall, Christian, PhD
Martin, Christa, PhD
Martinez-Agosto, Julian, MD. PhD
Matthews, Andrea, BS
McClure, Michelle, PhD
Might, Matthew, PhD
Miller, Jennifer, MD
Miller, Kristen Leppert, MGC, CGC
Moon-Grady, Anita, MD
Morava-Kozicz, Eva, MD, PhD
Morgan, Thomas, MD
Muthusamy, Karthik, MD
Nelson, Stanley, MD
Ngongang, Cedrik, MD
Niu, Zhiyv (Neal, PhD, FACMG
Oglesbee, Devin, PhD
Pagan, Jose, PhD
Pal, Tuya, MD
Pekarek, Dawn, MD
Perales Clemente, Ester, PhD
Pina-Aguilar, Raul, PhD, MD
Popejoy, Alice, PhD
Prakash, Siddharth, MD, PhD
Puffenberger, Erik, PhD
Quintero-Rivera, Fabiola, MD
Rahm, Alanna, PhD, LGC
Raraigh, Karen MS
Rasmussen, Sonja, MD, MS, FACMG
Rehm, Heidi, PhD, FACMG
Roberts, Jessica, JD
Rose, Sherrill, MD
Rotberg, Seth, MS
Russell, Bianca, MD
Sadikovic, Bekim, PhD
Samango-Sprouse, Carole, EdD
Schaaf, Christian, MD, PhD
Scheuner, Maren, MD, MS
Scott, Richard, MD, PhD
Seaver, Laurie, MD
Shaffer, Brian, MD, FACOG, FACMG
Shashi, Vandana, MD
Shieh, Joseph, MD, PhD
Shinawi, Marwan, MD
Slavotinek, Anne, MD, PhD
Soler-Alfonso, Claudia, MD
Slutsky, Emily, MD, MS
Stover, Samantha, CGC
Smith, Jessica, MD, FACMG, FACOG
Suskin, Barrie, MD
Sutherland, Nykole, MS
Tan, Khoon Ghee Queenie, MD, PhD
Tan, Wen-Hann, MD
Tatton-Brown, Katrina, MD
Terraf, Panieh, MSc, PhD
Tucci, Arianna, MD PhD
Vockley, Jerry, MD, PhD
Walton, Nephi, MD, MS
Wapner, Ronald, MD
Weck, Karen, MD, FCAP
Weksberg, Rosanna, MD, PhD
Williams, Eli, PhD
Wolff, Daynna, PhD
Yang, Chen, MD, PhD
Yap, Kai Lee, PhD
Sessions
Laboratory Diagnostic Challenges (Constitutional and Neoplastic Cases in Molecular, Cytogenomic, and Biochemical Genetics Specialties)
Genomic Informatics on Clinical Service and Approaches to Evaluate the Unknown/Uncertain: An Interactive Workshop
Chromatinopathies: An Expanding Clinical Spectrum
The Heart of the Matter - Congenital Cardiac Disease and Pregnancy
Heritable Human Genome Editing in Clinical Practice: Scientific, Social, Ethical, and Legal Perspectives
Adult and Cancer Diagnostic Challenges
Excellence in Medical Genetics and Genomics Through Diversity
Telegenetics: Before, During and After COVID-19
Gene-Based Medicines to Treat Metabolic Disorders: Progress and Perspectives
Hot Topics: Pushing the Boundaries of Genome Sequencing
Genetic Counselor Forum: In Utero Fetal Molecular Therapies: Present State and Future Applications
Pediatric Tumor Predisposition Syndromes: Update on Clinical Phenotypes, Associated Tumors, and Clinical Approaches to Surveillance
RNA and Gene Therapy in the Clinic – From Discovery to Treatment Implementation
Implementation of Whole Genome Sequencing as an Example of How to Bridge the Divide Between Research and Clinical Practice
Prenatal Diagnostic Challenges
Sex Chromosome Trisomies - To Screen or Not to Screen? - That is the Question
Bringing the New Era of Mitochondrial Genomic Medicine to Geneticists
Unexpected Findings Across the Lifespan: Challenges of Reporting Incidental and Secondary Findings in Young Patients
A Primer on Regulatory and Compliance Agencies in Genetic Testing
Artificial Intelligence and Genomics – Powerful Tools in Pre- and Postnatal Decision Making
The Ehlers-Danlos Syndromes, Circa 2021: Clinical and Molecular Updates
What’s in a Panel? A Decade of Expanded Carrier Screening in Review
The Intersection Between Developmental Phenotypes and Perinatal Genomic Diagnoses
Clinical Pharmacogenomic Testing: Current Best Practices and Future Landscape
Genetic Health Disparities: From Biology to Healthcare Delivery Systems
ACMG 2021 Cardinal Signs
R. Rodney Howell Symposium | Genetics in Medicine Presents: Spring 2021 COVID-19 State of the Science
Plain People, Precision Medicine, and the Legacy of Victor McKusick
Power in Numbers: The Benefits of Rare Disease Consortia in Inborn Errors of Metabolism
Looking Beyond the Lamppost: Genome-First Approaches to Disease Prevalence, Penetrance, and Phenotype
The Evolution of Autopsy in the Era of Sequencing
Clinical, Legal, Ethical, and Economic Issues Surrounding Variant Reinterpretation
Diversity in Clinical Genetics Practices Around the World
Featured Platform Presentations
Platform Presentations- Cancer Genetics and Therapeutics
Platform Presentations -Genetic Counseling
Platform Presentations- Legal and Ethical Issues; Education
Platform Presentations- Clinical Genetics and Therapeutics
Platform Presentations- Public Health, Health Services and Implementation
Platform Presentations- Prenatal Genetics
Platform Presentations- Biochemical/Metabolic Genetics
Platform Presentations- Laboratory Genetics and Genomics
© 2023 American College of Medical Genetics and Genomics. All rights reserved.